BIIB - Biogen slips as outlook disappoints amid flat Leqembi sales
2024-02-13 07:59:24 ET
More on Biogen
- Biotech And Pharma Diversification Pays Off
- Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Biogen: LEQEMBI's $10 Billion Potential
- Biogen misses top-line and bottom-line estimates; initiates FY24 outlook
- Biogen gets EU approval for Friedrich's ataxia drug